Targazyme Inc - Company Review
Targazyme Inc - Company ReviewSummary
Targazyme Inc (Targazyme), formerly America Stem Cell Inc is biopharmaceutical company that develops and commercializes clinical products in the fields of cell and immunotherapy.The company's products include TZ101 and TZ102. Its TZ101 is used in preclinical experiments from various academic institutions and also in preclinical animal studies. Targazyme's product TZ102 is used to treat for patients with neurodegenerative diseases such as neural stem cells for multiple sclerosis, stroke, and cancer. The company develops applications which include hematopoietic stem cell transplants, immunotherapies for solid tumors, cell therapies to ameliorate graft-versus-host and autoimmune diseases, and cell therapies for ischemic diseases. It operates in the US and Switzerland. Targazyme is headquartered in Carlsbad, California, the US.
This comprehensive company report of Targazyme Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.